Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
25 studies found for:    " July 09, 2008":" August 08, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
Condition: Human Immunodeficiency Virus Infections
Interventions: Drug: Efavirenz 600mg;   Drug: Boosted Lexiva
22 Completed Cognitive Behavioral Stress Management for HIV+ Drug Abusers
Conditions: HIV/AIDS;   Drug Abuse;   Alcohol Abuse
Intervention: Behavioral: Cognitive Behavioral Stress Management
23 Unknown  Women-Focused HIV Prevention in the Western Cape
Conditions: HIV;   Substance Abuse;   Violence
Interventions: Behavioral: Woman-Focused Intervention (Women's CoOp);   Behavioral: Nutrition (Attention-Control);   Behavioral: VCT Only
24 Terminated Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
Conditions: HIV-associated Neuropathy;   Polyneuropathy
Interventions: Drug: SAB378;   Drug: methadone;   Drug: SAB placebo;   Drug: Methadone placebo
25 Terminated
Has Results
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Pain;   Precancerous Condition;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methadone hydrochloride;   Drug: morphine sulfate;   Drug: oxycodone hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-25) Next Page   
Study has passed its completion date and status has not been verified in more than two years.